225 related articles for article (PubMed ID: 16000773)
1. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.
Hajjaj H; Macé C; Roberts M; Niederberger P; Fay LB
Appl Environ Microbiol; 2005 Jul; 71(7):3653-8. PubMed ID: 16000773
[TBL] [Abstract][Full Text] [Related]
2. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.
Komoda Y; Shimizu M; Sonoda Y; Sato Y
Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):531-3. PubMed ID: 2743504
[TBL] [Abstract][Full Text] [Related]
3. Lanosterol 14 alpha-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol.
Tuck SF; Patel H; Safi E; Robinson CH
J Lipid Res; 1991 Jun; 32(6):893-902. PubMed ID: 1940622
[TBL] [Abstract][Full Text] [Related]
4. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
Frye LL; Leonard DA
Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
[TBL] [Abstract][Full Text] [Related]
5. Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51).
Korosec T; Acimovic J; Seliskar M; Kocjan D; Tacer KF; Rozman D; Urleb U
Bioorg Med Chem; 2008 Jan; 16(1):209-21. PubMed ID: 17964172
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
Iglesias J; Gibbons GF
Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
[TBL] [Abstract][Full Text] [Related]
7. Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
Harwood HJ; Petras SF; Hoover DJ; Mankowski DC; Soliman VF; Sugarman ED; Hulin B; Kwon Y; Gibbs EM; Mayne JT; Treadway JL
J Lipid Res; 2005 Mar; 46(3):547-63. PubMed ID: 15604516
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells.
Mayer RJ; Adams JL; Bossard MJ; Berkhout TA
J Biol Chem; 1991 Oct; 266(30):20070-8. PubMed ID: 1657912
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.
Swinney DC; So OY; Watson DM; Berry PW; Webb AS; Kertesz DJ; Shelton EJ; Burton PM; Walker KA
Biochemistry; 1994 Apr; 33(15):4702-13. PubMed ID: 8161528
[TBL] [Abstract][Full Text] [Related]
10. Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum.
Fang QH; Zhong JJ
Biotechnol Prog; 2002; 18(1):51-4. PubMed ID: 11822899
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in p53-null HL-60 cells by inhibition of lanosterol 14-alpha demethylase.
Martínez-Botas J; Ferruelo AJ; Suárez Y; Gómez-Coronado D; Lasunción MA
Biochimie; 1998 Nov; 80(11):887-94. PubMed ID: 9893947
[TBL] [Abstract][Full Text] [Related]
12. Effects of 19-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and lanosterol demethylase activity.
Sonoda Y; Suzuki S; Udagawa K; Ota K; Tasaka R; Fukamachi Y; Sato Y
Biol Pharm Bull; 1996 Jan; 19(1):57-61. PubMed ID: 8820912
[TBL] [Abstract][Full Text] [Related]
13. Preparative isolation of ganoderic acid S, ganoderic acid T and ganoderol B from Ganoderma lucidum mycelia by high-speed counter-current chromatography.
Feng N; Wei Y; Feng J; Tang Q; Zhang Z; Zhang J; Han W
Biomed Chromatogr; 2018 Oct; 32(10):e4283. PubMed ID: 29748985
[TBL] [Abstract][Full Text] [Related]
14. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.
Trzaskos JM; Ko SS; Magolda RL; Favata MF; Fischer RT; Stam SH; Johnson PR; Gaylor JL
Biochemistry; 1995 Aug; 34(30):9670-6. PubMed ID: 7626636
[TBL] [Abstract][Full Text] [Related]
15. Biotechnological production and application of ganoderic acids.
Xu JW; Zhao W; Zhong JJ
Appl Microbiol Biotechnol; 2010 Jun; 87(2):457-66. PubMed ID: 20437236
[TBL] [Abstract][Full Text] [Related]
16. A novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom Ganoderma lucidum for the efficient production of ganoderic acid and Ganoderma polysaccharides.
Zhang W; Tang YJ
Biotechnol Prog; 2008; 24(6):1249-61. PubMed ID: 19194938
[TBL] [Abstract][Full Text] [Related]
17. Current progress in the study on biosynthesis and regulation of ganoderic acids.
Shi L; Ren A; Mu D; Zhao M
Appl Microbiol Biotechnol; 2010 Dec; 88(6):1243-51. PubMed ID: 20859739
[TBL] [Abstract][Full Text] [Related]
18. Enhanced biosynthetic gene expressions and production of ganoderic acids in static liquid culture of Ganoderma lucidum under phenobarbital induction.
Liang CX; Li YB; Xu JW; Wang JL; Miao XL; Tang YJ; Gu T; Zhong JJ
Appl Microbiol Biotechnol; 2010 May; 86(5):1367-74. PubMed ID: 20077112
[TBL] [Abstract][Full Text] [Related]
19. Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria.
Liu J; Shiono J; Shimizu K; Kondo R
Planta Med; 2010 Feb; 76(2):137-9. PubMed ID: 19670160
[TBL] [Abstract][Full Text] [Related]
20. Impact of oxygen level in gaseous phase on gene transcription and ganoderic acid biosynthesis in liquid static cultures of Ganoderma lucidum.
Zhang WX; Tang YJ; Zhong JJ
Bioprocess Biosyst Eng; 2010 Aug; 33(6):683-90. PubMed ID: 19809834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
